Coherus BioSciences Inc (NAS:CHRS)
$ 2.12 -0.05 (-2.3%) Market Cap: 243.22 Mil Enterprise Value: 464.61 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q1 2020 Coherus BioSciences Inc Earnings Call Transcript

May 07, 2020 / 08:30PM GMT
Release Date Price: $16.66 (+2.90%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Coherus BioSciences 2020 First Quarter Earnings Conference Call. My name is Lori, and I will be your conference operator for the call today. As a reminder, this conference call is being recorded.

I would now like to turn the call over to David Arrington, Coherus' Investor Relations and Corporate Affairs. Please go ahead.

David Arrington
Coherus BioSciences, Inc. - VP of IR & Corporate Affairs

Thank you, Lori, and good afternoon, everyone. After close of market today, we issued a press release on our first quarter financial results. This release can be found on the Coherus BioSciences website. Joining me for today's call will be Denny Lanfear, Coherus' CEO; Dr. Jean Viret, Chief Financial Officer; Thomas Fitzpatrick, Chief Legal Officer; and Chris Thompson, Executive Vice President, Sales and Market Access.

Before we begin our formal remarks, I would like to remind you that we will be making forward-looking statements, including risks and uncertainties related to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot